This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
VolitionRx ($VNRX) publishes peer-reviewed data showing its Capture-Seq liquid biopsy tech isolates 99%+ pure tumor DNA, with no false positives in early studies. The company targets a combined $36B+ market opportunity. #LiquidBiopsy #CancerDetection
2026-08-05T17:03:26.367Z